"LM_ID","COMMON_NAME","SYSTEMATIC_NAME","FORMULA","MASS","CATEGORY","MAIN_CLASS","SUB_CLASS","CLASS_LEVEL4","SYNONYMS","INCHI_KEY","INCHI","SMILES","KEGG_ID","HMDBID","CHEBI_ID","ABBREVIATION","PUBCHEM_COMPOUND_ID","LIPIDBANK_ID","SWISSLIPIDS_ID","CAYMAN_ID","ALT_CATEGORIES","ALT_MAIN_CLASSES","ALT_SUB_CLASSES","ALT_CLASS_LEVEL4S","TAXONOMY","CITATION"
"LMSP0505AO04","type II B antigen(d18:1/22:0)","Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)","C92H165N3O42","1984.086779","Sphingolipids [SP]","Neutral glycosphingolipids [SP05]","Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) [SP0505]","-","-","IFNBPZWOCWVGAR-PPHVTTLKSA-N","InChI=1S/C92H165N3O42/c1-6-8-10-12-14-16-18-20-21-22-23-24-25-27-29-31-33-35-37-39-60(106)95-51(52(105)38-36-34-32-30-28-26-19-17-15-13-11-9-7-2)47-122-87-75(119)72(116)80(59(46-102)130-87)132-91-77(121)82(66(110)55(42-98)126-91)135-85-61(93-49(4)103)68(112)78(57(44-100)128-85)131-90-76(120)81(65(109)54(41-97)125-90)134-86-62(94-50(5)104)69(113)79(58(45-101)129-86)133-92-84(137-88-73(117)70(114)63(107)48(3)123-88)83(67(111)56(43-99)127-92)136-89-74(118)71(115)64(108)53(40-96)124-89/h36,38,48,51-59,61-92,96-102,105,107-121H,6-35,37,39-47H2,1-5H3,(H,93,103)(H,94,104)(H,95,106)/b38-36+/t48-,51+,52-,53-,54-,55-,56-,57-,58-,59-,61-,62-,63-,64+,65+,66+,67+,68-,69-,70-,71+,72-,73+,74-,75-,76-,77-,78-,79-,80-,81+,82+,83+,84-,85+,86+,87-,88-,89-,90+,91+,92+/m1/s1","[C@](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@@H]5O[C@H](CO)[C@@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O[C@H]7O[C@H](CO)[C@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@H]6O[C@H](C)[C@@H](O)[C@@H](O)[C@@H]6O)[C@H](O)[C@H]5NC(=O)C)[C@H]4O)[C@H](O)[C@H]3NC(=O)C)[C@H]2O)[C@H](O)[C@H]1O)([H])(NC(CCCCCCCCCCCCCCCCCCCCC)=O)[C@]([H])(O)/C=C/CCCCCCCCCCCCC","-","-","-","Hex(5)-HexNAc(2)-Fuc-Cer 40:1;O2","44261087","-","-","-","-","-","-","-","-","-"